Skip to content

STUDY OF AYURVEDIC MANAGEMENT OF NEPHROTIC SYNDROME

EVALUATION OF MULTI-PHASIC OPTIMIZED AYURVEDIC MANAGEMENT IN THE PATIENTS OF PRIMARY NEPHROTIC SYNDROME

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011476
Enrollment
10
Registered
2018-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Primary Nephrotic syndrome patients

Interventions

Intervention1: Ayurvedic classical herbal formulation: 1.Vardhamana pippali rasayana kalpa: Fine powder of pippali (Piper longum Linn.) will be given in increasing and tapering dose-pattern. 2.Vireca

Sponsors

J S Ayurveda college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient who have confirmed diagnosis of Primary type of nephrotic syndrome (idiopathic) of both the genders and between 18 to 50 years of age group.

Exclusion criteria

Exclusion criteria: 1. Patients of nephrotic syndrome due to other disorders i.e SLE, Henoch Schonlein purpura, amyloidosis and infection with HIV, parvovirus B19 and hepatitis B and C viruses, Diabetes mellitus, Drug toxicity, any genetic disorders etc. 2. Patients having complication of nephrotic syndrome like CRF etc. 3. Patients who associated with some serious illness i.e. tuberculosis, cardio-vascular diseases, acute mental disorders, serious acute organic diseases, serious chronic co-morbidity, hypo or hyper thyroidism, Cushingâ??s syndrome, thromboembolic disorders etc. 4. Patients with an eGFR (glomerular filtration rate) less than 60 ml/min/1.73m2. 5. Female patients having pregnancy, lactating or post-delivery period. 6. Patients of nephrotic syndrome who are contraindicated for virecana.

Design outcomes

Secondary

MeasureTime frame
nilTimepoint: nil

Primary

MeasureTime frame
Effect of Ayurvedic management in the patient of primary Nephrotic syndrome.Timepoint: Grade score of sign and symptoms along with laboratory investigation before treatment and after treatment of 28 days

Countries

India

Contacts

Public ContactVikas C Patel

J S Ayurveda college Nadiad

guptayurveda@yahoo.com9825261305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026